Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company

Modern name, purpose, and visual identity mark inspiring next chapter for maker of iconic, trusted brands, including Tylenol, Neutrogena, Listerine, and Band-Aid Brand

Johnson & Johnson Prepares to Test IPO Waters

Johnson & Johnson's Kenvue Valued at $40 Billion Ahead of IPO

kenvue425-day1prexvueart

J&J forecasts 12.5% growth in 2023 profit after Kenvue spinoff

Wall Street Journal - J&J Says New Band-Aid and Tylenol Company to

Home Kenvue - A new view of care

J&J Tylenol Maker Kenvue Exchange Offer to Bring In Investors (JNJ

Johnson & Johnson plants sold for $59 million

Johnson & Johnson to Separate its Consumer Health Business

Why You Should Invest And Play Safe In J&J's Kenvue IPO

Inside J&J's 4-Month Process of Developing the Kenvue Brand

Johnson & Johnson's new company Kenvue, Starbucks announces

Kenvue Is a Timely Stock

Rizkiwati Fitriah Djangko on LinkedIn: Kenvue becomes a fully